Chemi Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEUPROLIDE ACETATE, with a corresponding US DMF Number 14763.
Remarkably, this DMF maintains an Active status since its submission on March 07, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 20, 2014, and payment made on January 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II